MacroGenics, Inc.

NASDAQ:MGNX

Biotechnology

Healthcare
$1.98 +2.02%

+$0.08 today

Market cap
$126.54M
Beta
1.20
P/E (TTM)
-3.6
EPS (TTM)
-$1.11
52W Low $1.19High $4.64

Volume 0.93M

Average 0.98M

Price history

MacroGenics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+39.44%

Period high

$4.86

Period low

$1.33

Latest

$1.98

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
8-KNov 13, 2026Nov 13, 2026
10-QNov 12, 2026Nov 12, 2026
8-KNov 12, 2026Nov 12, 2026
4Nov 3, 2026Nov 3, 2026
4Nov 3, 2026Nov 3, 2026
3Nov 3, 2026Nov 3, 2026
8-KNov 3, 2026Nov 3, 2026
3Nov 3, 2026Nov 3, 2026
8-KOct 23, 2026Oct 23, 2026
4Oct 7, 2026Oct 7, 2026
S-8Sep 3, 2026Sep 3, 2026
8-K/ASep 3, 2026Sep 3, 2026
4Aug 20, 2026Aug 20, 2026
4Aug 18, 2026Aug 18, 2026
SC 13G/AAug 14, 2026Aug 14, 2026

Competitors

Who does MacroGenics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about MGNX's filings, answered from its disclosures.

What is the latest MGNX filing?

The latest filing shown is 8-K dated Nov 13, 2026.

How many recent filings does MGNX have?

Intrinsic Alpha currently shows 20 recent filings for MGNX.